Study: Methods used to manage post-TAVR patients are safe

01/22/2013 | Healio

Warfarin plus a single antiplatelet drug or, if bleeding is an issue, warfarin alone were safe for patients following transcatheter aortic valve replacement, according to a study in the American Journal of Cardiology. "In general, we believe that patients who have indications for long-term anticoagulation should continue with this therapy irrespective of the TAVR procedure," the study's authors wrote.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA